StageZero Life Sciences Ltd (SZLS) — Capital Reinvestment Ratio
Latest as of March 2015:
0.00x
StageZero Life Sciences Ltd (SZLS) has a Capital Reinvestment Ratio of 0.00x as of March 2015, meaning it reinvests 0% of its operating cash flow (CA$187.19K) in capital expenditures (CA$608.14). Check tangible equity quality of StageZero Life Sciences Ltd to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
CA$187.19K
CAD
Capital Expenditures
CA$608.14
CAD
Data as of
Mar 2015
Most recent filing
Annual Capital Reinvestment Ratio for StageZero Life Sciences Ltd (None–None)
Year-by-year Capital Reinvestment Ratio for StageZero Life Sciences Ltd from None to None. See StageZero Life Sciences Ltd (SZLS) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CAD) | Capital Expenditures | YoY Change |
|---|
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow